Clinical Trial

Trial Protocol ID 1479-0001 *RIT*

Trial Description

An open label, Phase I dose escalation trial, with dose confirmation and expansion, of BI 1810631 as monotherapy in patients with advanced or metastatic solid tumors with HER2 aberrations

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Disease Types

Sponsor

  • Boehringer Ingelheim

ClinicalTrials.gov NCT ID

  • NCT04886804